Author: Hendriks MG/van Beijsterveldt BC//Schouten HC
Academisch Ziekenhuis, afd. Interne Geneeskunde, Maastricht
Conference/Journal: Ned Tijdschr Geneeskd
Date published: 1998
Other: Volume ID: 16 , Issue ID: 142 , Pages: 1152-5 , Word Count: 230
OBJECTIVE: To determine the quality of life in patients after high dose chemo/radiotherapy followed by bone marrow stem cell transplantation for the treatment of a malignancy. DESIGN: Structured questionnaire and in-depth interview. SETTING: Academic Hospital Maastricht, the Netherlands. METHODS: All patients who had undergone stem cell transplantation (SCT) at least 6 months previously (n = 54) were asked to participate in an analysis of their quality of life using the 'Quality of life questionnaire' (QLQ-C30) developed by the European Organization for Research and Treatment of Cancer (EORTC) and an in-depth interview. RESULTS: The EORTC QLQ-C30 was answered by 52 (96%) of the patients and 46 (85%) participated in the interview. The patients were divided in cohorts of 6-24 (n = 16), 25-48 (n = 22) and more than 48 months (n = 14) after SCT. Quality of life was 73.9 on a 100 per cent scale. There were no significant differences between various cohorts after SCT. However, patients transplanted more than 4 years before had significantly more complaints of nausea and vomiting. The structured interview revealed significant problems with fatigue, sexuality, finances and return to work. No clear relation with time elapsed after transplantation was found. CONCLUSION: SCT has a significant impact on several quality of life issues, which should be considered in the application of this modality in palliative situations. The EORTC QLQ-C30 may be helpful to analyse overall quality of life after transplantation, but provides no information on individual effects on quality of life.